Back to Agenda
Research in Participants with Progressive Cognitive Impairment: Best Practices for Ensuring Continuing Informed Consent
Session Chair(s)
Karla Childers, MS
Head, Bioethics-Based Science and Technology Policy
Johnson & Johnson, United States
The session will describe informed consent in research participants with cognitive decline, discussing behavioral cues and consent/assent requirements for ethical practices when participants lose the ability to provide informed consent during a study
Learning Objective : Understand the ethical and operational challenges of engaging participants with cognitive impairment; Describe ethical options for retaining participants with cognitive impairment in clinical trials; Review best practices for informed consent/ caregiver consent/participant assent when the ability to give consent is lost during the course of a trial
Speaker(s)

Sharing an IRB Perspective
Linda Reuter, MS
BRANY IRB, United States
Senior Director
Have an account?